J.P. Morgan analysts highlighted five income names for the coming year. All the stocks have an Overweight rating. Apollo ...
J.P. Morgan research shows high credit card debt lowers retirement plan balances and increases loan risk, impacting long-term savings.
Recursion Pharmaceuticals (RXRX) stock rises after J.P. Morgan upgraded the biotech, citing a $1B+ sales potential for the company's lead drug. Read more here.
24/7 Wall St. on MSN
Investors Say Europe Is Cooked, But JP Morgan’s Euro ETF Is Destroying The S&P and Hot AI Stocks
When currency swings punish domestic investors and geopolitical headlines scream crisis, the stocks underneath often tell a ...
IPOs don’t always get the attention they deserve, yet they play a vital role in renewing the stock market. They bring new ...
While Kotak has stayed on in the top 5, ICICI Bank saw the sharpest fall to 11th rank, falling out of the Top 5 for the first ...
Samsung Biologics said Sunday it will attend the upcoming 2026 J.P. Morgan Healthcare Conference, marking the 10th ...
J.P. Morgan Wealth Management has named John Pannozzo Regional Director for the Hudson Metro region. He will lead financial ...
Major banking firm J.P. Morgan has submitted a large planning application for a new five‑storey office building and a ...
In 2024, AbbVie’s presentation at the conference focused on its recent acquisitions of ImmunoGen and Cerevel. AbbVie paid ...
J.P. Morgan Private Bank expands in New Jersey with new leadership in Summit, with plans to hire 150 employees while serving wealthy clients.
J.P. Morgan identifies specific traits that define their Best Ideas for 2026. These companies typically possess: Strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results